Drug · DIN 02479664
HEMLIBRA
SINGLE-DOSE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 27, 2018; first marketed November 27, 2018.
- Drug Identification Number (DIN)
- 02479664
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Emicizumab B02BX06
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EMICIZUMAB | 150 MG | ML |
Other DINs named HEMLIBRA
- DIN 02479621 · Marketed
- DIN 02479648 · Marketed
- DIN 02479656 · Marketed
- DIN 02556049 · Marketed
- DIN 02556057 · Marketed